Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressor

Oncogene

Volumn 23, Issue 45, 2004, Pages 7561-7570

  Pike, Joanna ^a   Holmes, David ^a   Kamalati, Tahereh ^a   Davies, Derek ^b   Tolhurst, Robert ^a   Mazhar, Danish ^a   Fishpool, Sam ^a   Al Jehani, Rajai ^a   Waxman, Jonathan ^a   Zelent, Arthur ^c   Lemoine, Nicholas R ^a   Ali, Simak ^a   Buluwela, Laki ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Androgen receptor; Gene expression; PLZF; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; DNA; HYBRID PROTEIN; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL STRAIN COS1; GENE EXPRESSION; GENE SILENCING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS RECOMBINANT;

ANDROGENS; ANIMALS; BASE SEQUENCE; COS CELLS; DNA PRIMERS; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; HUMANS; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS;

ADENOVIRIDAE; ANIMALIA;

EID: 6344294360     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208030     Document Type: Article

References (59)

1. Ayer DE. (1999). Trends Cell Biol., 9, 193-198.
2. Berthois Y, Katzenellenbogen JA and Katzenellenbogen BS. (1986). Proc. Natl. Acad. Sci. USA, 83, 2496-2500.
3. Bevan CL, Hoare S, Claessens F, Heery DM and Parker MG. (1999). Mol. Cell. Biol., 19, 8383-8392.
4. Bird AP and Wolffe AP. (1999). Cell, 99, 451-454.
5. Blankvoort BM, de Groene EM, van Meeteren-Kreikamp AP, Witkamp RF, Rodenburg RJ and Aarts JM. (2001). Anal. Biochem., 298, 93-102.
6. Bramlett KS, Dits NF, Sui X, Jorge MC, Zhu X and Jenster G. (2001). Mol. Cell. Endocrinol., 183, 19-28.
7. Chawla A, Repa JJ, Evans RM and Mangelsdorf DJ. (2001). Science, 294, 1866-1870.
8. Chen D, Pace PE, Coombes RC and Ali S. (1999). Mol. Cell. Biol., 19, 1002-1015.
9. Chen SJ, Zelent A, Tong JH, Yu HQ, Wang ZY, Derre J, Berger R, Waxman S and Chen Z. (1993a). J. Clin. Invest., 91, 2260-2267.
10. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S and Zelent A. (1993b). EMBO J., 12, 1161-1167.
11. Cheung WL. Briggs SD and Allis CD. (2000). Curr. Opin. Cell. Biol., 12, 326-333.
12. Chung BH, Mitchell SH, Zhang JS and Young CY. (2001). Carcinogenesis, 22, 1201-1206.
13. Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW and Trapman J. (1997). Mol. Endocrinol., 11, 148-161.
14. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO and Trapman J. (1996). J. Biol. Chem., 271, 6379-6388.
15. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ and Sugimura Y. (1987). Endocr. Rev., 8, 338-362.
16. David G, Alland L, Hong SH, Wong CW, DePinho RA and Dejean A. (1998). Oncogene, 16, 2549-2556.
17. Davies P and Eaton CL. (1991). J. Endocrinol., 131, 5-17.
18. Dilworth FJ and Chambon P. (2001). Oncogene, 20, 3047-3054.
19. Feldman BJ and Feldman D. (2001). Nat. Rev. Cancer, 1, 34 45.
20. Glass CK and Rosenfeld MG. (2000). Genes Dev., 14, 121-141.
21. Green S, Issemann I and Sheer E. (1988). Nucleic Acids Res., 16, 369.
22. Greenlee RT, Murray T, Bolden S and Wingo PA. (2000). CA Cancer J. Clin., 50, 7-33.
23. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S and Pelicci PG. (1998). Nature, 391, 815-818.
24. Guidez F, Ivins S, Zhu J, Soderstrom M. Waxman S and Zelent A. (1998). Blood, 91, 2634-2642.
25. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi PP. (1998a). Nat. Genet., 18, 126-135.
26. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B. (1998b). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
27. Heemers H, Vanderhoydonc F, Heyns W, Verhoeven G and Swinnen JV. (2000). Biochem. Biophys. Res. Commun., 269, 209-212.
28. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK and Sandberg AA. (1980). Prog. Clin. Biol. Res., 37, 115-132.
29. Hsieh ML, Charlesworth MC, Goodmanson M, Zhang S, Seay T, Klee GG, Tindall DJ and Young CY. (1997). Cancer Res., 57, 2651-2656.
30. Huggins C. (1967). Cancer Res., 27, 1925-1930.
31. Labrie F, Belanger A, Dupont A, Luu-The V, Simard J and Labrie C. (1993). Clin. Invest. Med., 16, 475-492.
32. Labrie F, Dupont A, Belanger A, St-Arnaud R, Giguere M, Lacourciere Y, Emond J and Monfelte G. (1986). Endocr. Rev., 7, 67-74.
33. Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH and Evans RM. (1998). Nature, 391, 811-814.
34. Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC and Buluwela L. (1996). Cancer Res., 56, 1155-1163.
35. Mabjeesh NJ, Zhong H and Simons JW. (2002). Endocr. Relat. Cancer, 9, 115-139.
36. McKenna NJ and O'Malley BW. (2002). Cell, 108, 465-474.
37. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G and Pinsky L. (1993). Nat. Genet., 5, 184-188.
38. Monne M, Croce CM, Yu H and Diamandis EP. (1994). Cancer Res., 54, 6344-6347.
39. Montgomery JS, Price DK and Figg WD. (2001). J. Pathol., 195, 138-146.
40. Narlikar GJ, Fan HY and Kingston RE. (2002). Cell, 108, 475-487.
41. Razin A and Riggs AD. (1980). Science, 210, 604-610.
42. Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R and Zelent A. (1995). Blood, 86, 4544-4552.
43. Roth SY, Denu JM and Allis CD. (2001). Annu. Rev. Biochem., 70, 81-120.
44. Sadi MV, Walsh PC and Barrack ER. (1991). Cancer, 67, 3057-3064.
45. Schwabe JW, Chapman L, Finch JT and Rhodes D. (1993). Cell, 75, 567-578.
46. Shang Y and Brown M. (2002). Science, 295, 2465-2468.
47. Takane KK and McPhaul MJ. (1996). Mol. Cell. Endocrinol., 119, 83-93.
48. Tomura A, Goto K, Morinaga H, Nomura M, Okabe T, Yanase T, Takayanagi R and Nawata H. (2001). J. Biol. Chem., 276, 28395-28401.
49. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I and Chambon P. (1989). EMBO J., 8, 1981-1986.
50. Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B and Roy AK. (2000). Mol. Endocrinol., 14, 1162-1174.
51. Ulrix W, Swinnen JV, Heyns W and Verhoeven G. (1999). FEBS Lett, 455, 23-26.
52. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W and Trapman J. (1991). Int. J. Cancer, 48, 189-193.
53. Wong CW and Privalsky ML. (1998). J. Biol. Chem., 273, 27695-27702.
54. Workman JL and Kingston RE. (1998). Annu. Rev. Biochem., 67, 545-579.
55. Zegers ND, Claassen E, Neelen C, Mulder E, van Laar JH, Voorhorst MM, Berrevoets CA, Brinkmann AO, van der Kwast TH, Ruizeveld de Winter JA, Trapman J and Boersma WJA. (1991). Biochim. Biophys. Acta, 1073, 23-32.
56. Zelent A, Guidez F, Melnick A, Waxman S and Licht JD. (2001). Oncogene, 20, 7186-7203.
57. Zhang Y, LeRoy G, Seelig HP, Lane WS and Reinberg D. (1998). Cell, 95, 279-289.
58. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A and Reinberg D. (1999). Genes Dev., 13, 1924-1935.
59. Zhou ZX, Sar M, Simental JA, Lane MV and Wilson EM. (1994). J. Biol. Chem., 269, 13115-13123.